TY - JOUR
T1 - Inspiratory capacity-to-total lung capacity ratio and dyspnoea predict exercise capacity decline in COPD
AU - Ramon, Maria A.
AU - Ferrer, Jaume
AU - Gimeno-Santos, Elena
AU - Donaire-Gonzalez, David
AU - Rodríguez, Esther
AU - Balcells, Eva
AU - De Batlle, Jordi
AU - Benet, Marta
AU - Guerra, Stefano
AU - Sauleda, Jaume
AU - Ferrer, Antoni
AU - Farrero, Eva
AU - Gea, Joaquim
AU - Barberà, Joan A.
AU - Agustí, Alvar
AU - Rodriguez-Roisin, Robert
AU - Antó, Josep M.
AU - Garcia-Aymerich, Judith
N1 - Publisher Copyright:
© 2015 Asian Pacific Society of Respirology.
PY - 2016/4/1
Y1 - 2016/4/1
N2 - Background and objective Exercise capacity decline is a predictor of mortality in patients with chronic obstructive pulmonary disease (COPD). Static pulmonary hyperinflation is a key determinant of exercise performance, but its effect on the longitudinal decline in exercise capacity remains unknown. We aimed to study the relationship between the inspiratory capacity-to-total lung capacity (IC/TLC) ratio and exercise capacity decline in COPD. Methods We measured IC/TLC and other relevant clinical and functional variables in 342 clinically stable patients with COPD. The 6-min walk distance (6MWD) was determined at recruitment and after a mean ± SD of 1.7 ± 0.3 years. The annual rate of change in 6MWD was calculated. Multiple imputation to account for losses during follow up was implemented, and multivariate regression was used to analyze predictive factors of 6MWD decline. Results Mean decline rate in the 6MWD was 21.9 ± 34.1 m/year. In the bivariate analysis, patients with lower levels of IC/TLC had greater 6MWD decline (-27.4 ± 42.5, -24.9 ± 36.5 and -13.4 ± 39.9 m/year in the first, second and third tertile of IC/TLC, respectively; P-for-trend = 0.018). From other potential risk factors considered, dyspnoea, health status, serum C-reactive protein and Borg dyspnoea score at the end of the exercise test were related to exercise capacity decline. In the multivariate regression model, only IC/TLC (β = 0.7 m/year per each percentage unit of IC/TLC; P = 0.007) and dyspnoea (mMRC ≥ 2) (β = -14.6 m/year; P = 0.013) were associated with the annual rate of 6MWD change. Conclusion IC/TLC and dyspnoea in clinically stable patients with COPD predict their exercise capacity decline and may help to guide early therapeutic interventions.
AB - Background and objective Exercise capacity decline is a predictor of mortality in patients with chronic obstructive pulmonary disease (COPD). Static pulmonary hyperinflation is a key determinant of exercise performance, but its effect on the longitudinal decline in exercise capacity remains unknown. We aimed to study the relationship between the inspiratory capacity-to-total lung capacity (IC/TLC) ratio and exercise capacity decline in COPD. Methods We measured IC/TLC and other relevant clinical and functional variables in 342 clinically stable patients with COPD. The 6-min walk distance (6MWD) was determined at recruitment and after a mean ± SD of 1.7 ± 0.3 years. The annual rate of change in 6MWD was calculated. Multiple imputation to account for losses during follow up was implemented, and multivariate regression was used to analyze predictive factors of 6MWD decline. Results Mean decline rate in the 6MWD was 21.9 ± 34.1 m/year. In the bivariate analysis, patients with lower levels of IC/TLC had greater 6MWD decline (-27.4 ± 42.5, -24.9 ± 36.5 and -13.4 ± 39.9 m/year in the first, second and third tertile of IC/TLC, respectively; P-for-trend = 0.018). From other potential risk factors considered, dyspnoea, health status, serum C-reactive protein and Borg dyspnoea score at the end of the exercise test were related to exercise capacity decline. In the multivariate regression model, only IC/TLC (β = 0.7 m/year per each percentage unit of IC/TLC; P = 0.007) and dyspnoea (mMRC ≥ 2) (β = -14.6 m/year; P = 0.013) were associated with the annual rate of 6MWD change. Conclusion IC/TLC and dyspnoea in clinically stable patients with COPD predict their exercise capacity decline and may help to guide early therapeutic interventions.
KW - 6-min walk distance
KW - Chronic obstructive pulmonary disease
KW - Cohort study
KW - Disease progression
KW - Exercise capacity
UR - http://www.scopus.com/inward/record.url?scp=84952815409&partnerID=8YFLogxK
U2 - 10.1111/resp.12723
DO - 10.1111/resp.12723
M3 - Article
C2 - 26714424
AN - SCOPUS:84952815409
SN - 1323-7799
VL - 21
SP - 476
EP - 482
JO - Respirology
JF - Respirology
IS - 3
ER -